Evidence map›Paper›PMID 28457184›Full record

ArticleThyroid : official journal of the American Thyroid Association2017

Changes in Hepatic TRβ Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model.

Kenji Ohba, Rohit Anthony Sinha, Brijesh Kumar Singh, Liliana Felicia Iannucci, Jin Zhou, Jean-Paul Kovalik, Xiao-Hui Liao, Samuel Refetoff, Judy Chia Ghee Sng, Melvin Khee-Shing Leow and 1 more

Abstract read
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kenji Ohba1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Rohit Anthony Sinha1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Brijesh Kumar Singh1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Liliana Felicia Iannucci1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Jin Zhou1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Jean-Paul Kovalik1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Xiao-Hui Liao2 Department of Medicine, The University of Chicago , Chicago, Illinois.
Samuel Refetoff2 Department of Medicine, The University of Chicago , Chicago, Illinois.
Judy Chia Ghee Sng4 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore .
Melvin Khee-Shing Leow5 Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore .
Paul Michael Yen1 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School , Singapore, Singapore .
Duke-NUS Medical School · SGUniversity of Chicago · USAgency for Science, Technology and Research · SGNational University of Singapore · SG

Funding

THYROID PHYSIOLOGY STUDIES OF INHERITED DISORDERSR37DK015070 · NIDDK · UNIVERSITY OF CHICAGO · PI REFETOFF, SAMUEL · 1989 to 2015
$5.6M
NIDDK NIH HHS R37 DK015070
6 · The paper itself

Abstract

backgroundThyroid hormone (TH) has important roles in regulating hepatic metabolism. It was previously reported that most hepatic genes activated by a single triiodothyronine (T3) injection became desensitized after multiple injections, and that approximately 10% of target genes did not return to basal expression levels after T3 withdrawal, despite normalization of serum TH and thyrotropin (TSH) levels. To determine the possible mechanism(s) for desensitization and incomplete recovery of hepatic target gene transcription and their effects on metabolism, mRNA and/or protein expression levels of key regulators of TH action were measured, as well as metabolomic changes after chronic T3 treatment and withdrawal.

methodsAdult male mice were treated with daily injections of T3 (20 μg/100 g body weight) for 14 days followed by the cessation of T3 for 10 days. Livers were harvested at 6 hours, 24 hours, and 14 days after the first T3 injection, and at 10 days after withdrawal, and then analyzed by quantitative reverse transcription polymerase chain reaction, Western blotting, and metabolomics.

resultsAlthough TH receptor (TRα and TRβ) mRNAs decreased slightly after chronic T3 treatment, only TRβ protein decreased before returning to basal expression level after withdrawal. The expression of other regulators of TH action was unchanged. TRβ protein expression was also decreased in adult male monocarboxylate transporter-8 (Mct8)-knockout mice, an in vivo model of chronic intrahepatic hyperthyroidism. Previously, increased hepatic long-chain acylcarnitine levels were found after acute TH treatment. However, in this study, long-chain acylcarnitine levels were unchanged after chronic T3, and paradoxically increased after T3 withdrawal. Pathway analyses of the previous microarray results showed upregulation of lipogenic genes after acute T3 treatment and withdrawal. Phosphorylation of acetyl-CoA carboxylase also decreased after T3 withdrawal.

conclusionsDecreased hepatic TRβ protein expression occurred after chronic T3 exposure in adult male wild-type and Mct8-knockout mice. Gene array pathway and metabolomics analyses showed abnormalities in hepatic lipogenic gene expression and acylcarnitine levels, respectively, after withdrawal, despite normalization of serum TSH and TH levels. These findings may help explain the variable clinical presentations of some patients during hyperthyroidism and recovery, since TRβ protein, target gene expression, and metabolic adaptive changes can occur in individual tissues without necessarily being reflected by circulating TH and TSH concentrations.

Indexed as

Gene Expression RegulationAdipogenesisAnimalsBody WeightCarnitineChronic DiseaseDisease Models, AnimalHyperthyroidismLipogenesisLiverMaleMetabolomicsMiceMice, Inbred C57BLMice, KnockoutThyroid Hormone Receptors betaacylcarnitineCarnitineThyroid Hormone Receptors betaThyroid HormonesTriiodothyroninegene expressionlipogenesistemporal adaptationthyroid hormone receptorubiquitin-proteasome pathway

Identifiers

PMID28457184
PMCPMC5467114
OpenAlexW2609170535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.